Today: 12 April 2026
Subscribe

ON Semiconductor (ON) Stock Surges on Q3 Earnings Beat – Latest News, Financials, and Outlook

ON Semiconductor (ON) Stock Surges on Q3 Earnings Beat – Latest News, Financials, and Outlook

ON Semiconductor reported Q3 2025 net income of $255 million, or $0.63 per share, beating analyst estimates. Revenue reached $1.55 billion. The stock is down 10% year-to-date and 24% over 12 months, lagging sector gains. Analysts rate ON a “Moderate Buy,” with a $57–58 average price target, and expect a rebound in 2026 after a projected 42% EPS drop in 2025.
3 November 2025
··
UniQure’s Roller-Coaster: Gene Therapy Breakthrough, FDA Setback, and What’s Next for QURE Stock

UniQure’s Roller-Coaster: Gene Therapy Breakthrough, FDA Setback, and What’s Next for QURE Stock

UniQure shares plunged nearly 65% to $23–24 midday Nov. 3 after the FDA ruled current Huntington’s trial data insufficient for approval, erasing billions in market value. The company had raised $345 million in September at $47.50/share following a surge on positive trial results. Q2 revenue was $5.3 million, with a net loss of $37.7 million. Cash reserves rose to about $550 million after the equity raise.
3 November 2025
··
MongoDB’s CEO Shake-Up: 11-Year Veteran Departs as Cloudflare Exec Takes Charge Amid Stock Surge

MongoDB’s CEO Shake-Up: 11-Year Veteran Departs as Cloudflare Exec Takes Charge Amid Stock Surge

MongoDB named Chirantan “CJ” Desai as its next CEO, replacing Dev Ittycheria, who will step down in November 2025 after 11 years. Shares jumped about 9% in pre-market trading, nearing all-time highs, as the company raised its Q3 FY2026 outlook and analysts boosted price targets. Ittycheria will stay on as an advisor during the transition. Final Q3 results are due December 1, 2025.
3 November 2025
····
Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer (PFE) Stock at a Crossroads: Big Dividend, Weight-Loss Gamble & 2025 Outlook

Pfizer shares traded at $24.65 on Nov. 3, 2025, down about 3% year-to-date and over 50% from pandemic highs. The company reports Q3 results Nov. 4, with analysts expecting $16.6 billion in revenue and $0.66 EPS. Pfizer completed a $43 billion Seagen acquisition and is in a bidding war with Novo Nordisk over Metsera. The quarterly dividend is $0.43 per share, yielding around 7%.
3 November 2025
··
Amazon Stock Skyrockets to Record High on AWS Boom – Analysts Predict More Upside

Amazon Stock Skyrockets to Record High on AWS Boom – Analysts Predict More Upside

Amazon shares hit a record high near $244 on Oct. 31, 2025, after surging almost 10% on strong Q3 results. Revenue reached $180.2 billion and net income jumped to $21.2 billion, boosted by a $9.5 billion gain from its Anthropic investment. AWS revenue grew 20% to $33 billion, easing cloud slowdown fears. Wall Street raised price targets, with some analysts now valuing Amazon near $300 per share.
3 November 2025
···
Opendoor Stock Skyrockets 1300% Amid Meme Hype – Will the Rally Survive the Housing Slump?

Opendoor Stock Skyrockets 1300% Amid Meme Hype – Will the Rally Survive the Housing Slump?

Opendoor Technologies shares surged 1,300% from June lows, averting Nasdaq delisting and prompting the company to cancel a planned reverse split. Despite the rally, Opendoor posted a $29 million Q2 loss and expects Q3 revenue to fall sharply. The company named Kaz Nejatian CEO in September, shifting focus to AI-powered real estate. Wall Street analysts remain skeptical, with price targets below current levels.
3 November 2025
··
Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet?

Acrivon Therapeutics (ACRV): Precision Oncology Game-Changer or Overhyped Biotech Bet?

Acrivon Therapeutics shares jumped about 14% pre-market Nov. 3, 2025, trading near $2.27, down roughly 85% from its $12.50 IPO in 2022. Interim Phase 2b data for lead drug ACR-368 showed a 35% response rate in advanced endometrial cancer. The FDA granted Fast Track status to ACR-368 and Breakthrough Device designation to its companion diagnostic. Acrivon employs around 78 people in Watertown, MA.
3 November 2025
··
NIO Stock Skyrockets on Record Sales and Bold Moves – Can the Rally Last?

NIO Stock Skyrockets on Record Sales and Bold Moves – Can the Rally Last?

NIO delivered a record 40,397 vehicles in October 2025, up 92.6% year-over-year, pushing its stock to $7.25 after a sharp weekly rise. The company’s Onvo L90 SUV topped 10,000 units for a third month. NIO plans to expand into seven new European countries and hit 90 million battery swaps in October. Year-to-date, NIO shares are up about 60–66% but remain below 2021 highs.
3 November 2025
··
TGE Stock’s Wild Ride: Why The Generation Essentials Group Is Making Headlines in Nov 2025

TGE Stock’s Wild Ride: Why The Generation Essentials Group Is Making Headlines in Nov 2025

Generation Essentials Group (NYSE: TGE) stock plunged 54% to $0.78 on Oct. 31, 2025, then rebounded nearly 80% in early November. The company announced a $5 million share buyback and reported first-half 2025 revenue up 160% to $87.4 million. TGE holds $405 million in liabilities and faces tight liquidity, with analysts cautious and legal risks reported. The France-based media and hospitality firm went public via SPAC in mid-2025.
3 November 2025
·
IDEXX Laboratories (IDXX): Inside the Pet Diagnostics Leader’s 2025 Breakout 🚀

IDEXX Laboratories (IDXX): Inside the Pet Diagnostics Leader’s 2025 Breakout 🚀

IDEXX Laboratories reported Q3 2025 revenue of $1.11 billion, up 13%, and EPS of $3.40, up 21%, beating expectations and raising full-year guidance. Shares have surged about 50–55% year-to-date, trading near all-time highs. The company holds nearly half the global veterinary diagnostics market and generates about 79% of sales from recurring revenue. Institutional ownership stands at approximately 94%.
3 November 2025
·
Rani Therapeutics (RANI) Stock Skyrockets on Biotech Breakthrough: Inside the Surge and What’s Next

Rani Therapeutics (RANI) Stock Skyrockets on Biotech Breakthrough: Inside the Surge and What’s Next

Rani Therapeutics shares surged over 300% in a month, jumping to $2.20–$2.50 after announcing a partnership with Chugai Pharmaceutical worth up to $1.085 billion. The deal brought $10 million upfront and extended Rani’s cash runway into 2028 with a $60.3 million financing. Analyst targets rose as high as $11. Trading volume spiked tenfold, with the stock breaking key technical levels.
3 November 2025
··
MSP Recovery (MSPR) Stock Skyrockets 100% Amid Delisting Drama – What’s Next for This Troubled Company?

MSP Recovery (MSPR) Stock Skyrockets 100% Amid Delisting Drama – What’s Next for This Troubled Company?

MSP Recovery shares closed at $0.22 on Nov. 3 after swinging from $0.19 to $0.70 in volatile trading, erasing a pre-market surge. The stock has lost over 99% from its 52-week high and faces possible Nasdaq delisting. The company recently secured interim funding and executed a 1-for-7 reverse split. MSPR, a healthcare claims recovery firm, remains deeply unprofitable despite claims of $1 billion in potential assets.
3 November 2025
·
Dell Stock Skyrockets on AI Boom – Price Surge, Key News & 2025 Outlook

Dell Stock Skyrockets on AI Boom – Price Surge, Key News & 2025 Outlook

Dell shares traded near $162 on Nov. 3, 2025, close to their 52-week high after surging on news of a $5.8 billion AI hardware deal with Microsoft. The stock has more than doubled over the past year and is up 35% year-to-date, far outpacing the S&P 500. Analysts have raised price targets following Dell’s updated growth forecasts and strong demand for its AI infrastructure products.
3 November 2025
··
ALPS Group (NASDAQ: ALPS) Stock’s Wild Debut – Biotech Unicorn’s SPAC Merger Sparks Volatile Trading

ALPS Group (NASDAQ: ALPS) Stock’s Wild Debut – Biotech Unicorn’s SPAC Merger Sparks Volatile Trading

ALPS Group Inc. closed its Nasdaq debut at $2.56 per share on Oct. 31, 2025, after a SPAC merger, then plunged about 34% to $1.69 in pre-market trading Nov. 3. The Malaysian biotech’s public float was limited to roughly 3.5 million shares, fueling sharp volatility. Most shares remain locked up with insiders. The company raised $3.1 million in a concurrent PIPE.
3 November 2025
·
Datavault AI (DVLT) Stock Skyrockets on AI Frenzy – Key Facts & Future Outlook

Datavault AI (DVLT) Stock Skyrockets on AI Frenzy – Key Facts & Future Outlook

Datavault AI Inc. closed at $2.03 on Oct. 31, 2025, with a market cap near $600 million after a volatile year that saw shares swing from $0.25 to $4.10. The stock jumped 315% in Q3 but fell 40% in late October following a short-seller attack. DVLT remains unprofitable, reporting $0.63 million in revenue and a $9.56 million net loss over the past year. The company holds over 70 patents in AI, blockchain, and acoustic tech.
3 November 2025
···
AMTD Digital (HKD) Skyrockets 180% on 1,085% Revenue Surge – Meme-Stock Mania 2.0 or Sustainable Comeback?

AMTD Digital (HKD) Skyrockets 180% on 1,085% Revenue Surge – Meme-Stock Mania 2.0 or Sustainable Comeback?

AMTD Digital shares surged 224% to a $5.47 intraday high on Oct. 31, 2025, before closing up 75% at $2.95, with trading volume topping 323 million shares. The company reported a 1,085.9% year-over-year revenue jump to $73.2 million for the half-year ended April 2025, driven by its TGE acquisition. Net profit hit $51.5 million, but most gains came from one-off investment income. HKD now trades near $3.00.
3 November 2025
·
Micron’s AI-Fueled Stock Surge: Record Earnings, Rallying Shares & What’s Next for MU

Micron’s AI-Fueled Stock Surge: Record Earnings, Rallying Shares & What’s Next for MU

Micron Technology shares have surged over 140% in 2025, recently trading near $224, driven by record AI chip demand. Fiscal Q4 revenue hit $11.3 billion, up 46% year-on-year, with earnings of $3.03 per share. The company forecasts up to $12.8 billion in Q1 FY2026 revenue, citing sold-out high-bandwidth memory chips. Micron will halt some server chip sales to China after a 2023 ban.
3 November 2025
···
Interstellar Comet 3I/ATLAS Stuns Scientists – Brightening, Blue Glow & Mystery Acceleration

Interstellar Comet 3I/ATLAS Stuns Scientists – Brightening, Blue Glow & Mystery Acceleration

Comet 3I/ATLAS, the third known interstellar object to enter the solar system, was discovered July 1, 2025, by the ATLAS survey in Chile. It reached perihelion near October 29, passing just inside Mars’s orbit and brightening unusually fast while turning blue. NASA reported non-gravitational acceleration, likely from intense outgassing. Nickel vapor was detected in its coma at distances too cold for such metals to normally vaporize.
3 November 2025
·
1 … 1,587 1,588 1,589 1,590 1,591 … 1,848

Stock Market Today

  • Morgan Stanley Unveils Cheapest Spot Bitcoin ETF MSBT with Strong Launch
    April 11, 2026, 10:25 PM EDT. Morgan Stanley has launched the MSBT, the lowest-cost spot Bitcoin ETF in the U.S., charging an annual fee of just 0.14%, undercutting rivals like BlackRock's IBIT at 0.25%. MSBT drew about $34 million in inflows on its opening day with 1.6 million shares traded, marking a standout ETF debut, according to Bloomberg analyst Eric Balchunas. The new ETF gives Morgan Stanley's 16,000 financial advisors a direct way to offer Bitcoin exposure to clients, keeping fees within the bank rather than sending assets to competitors. This move positions Morgan Stanley uniquely in the growing Bitcoin ETF space, which has seen positive inflows recently after months of outflows. The fee advantage especially benefits high-net-worth clients investing six or seven figures.

Latest article

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

11 April 2026
Snowflake shares fell 8.4% to $121.11 on Friday after an 11.7% drop Thursday, as investors sold off software stocks amid concerns over new AI tools from Anthropic and OpenAI. The stock now trades just above its 52-week low. The S&P 500 Software and Services Index is down 25.5% for the year. Snowflake reported fourth-quarter product revenue of $1.23 billion, up 30% from a year earlier.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 11.04.2026

11 April 2026
LIVEMarkets rolling coverageStarted: April 11, 2026, 12:00 AM EDTUpdated: April 11, 2026, 10:50 PM EDT Morgan Stanley Unveils Cheapest Spot Bitcoin ETF MSBT with Strong Launch April 11, 2026, 10:25 PM EDT. Morgan Stanley has launched the MSBT, the **lowest-cost spot Bitcoin ETF** in the U.S., charging an annual fee of just 0.14%, undercutting rivals like BlackRock's IBIT at 0.25%. MSBT drew about $34 million in inflows on its opening day with 1.6 million shares traded, marking a standout ETF debut, according to Bloomberg analyst Eric Balchunas. The new ETF gives Morgan Stanley's 16,000 financial advisors a direct way to
Go toTop